Table 2.
Comparison of SSAs according to AXIN2 expression status
| Group 2B-1 (n = 8) | Group 2B-2 (n = 11) | P-value 4 | |
|---|---|---|---|
|
Gender (Male/Female) |
4/4 |
9/2 |
0.32 |
|
Patient Age (years) |
62.8 ± 9.9 |
59.1 ± 9.9 |
0.44 |
|
(Range, Median) |
(46–74, 63) |
(40–76, 59) |
|
|
Tumor Size (mm) |
9.4 ± 1.9 |
15.3 ± 6.1 |
0.01 |
|
(Range, Median) |
(6–12, 10) |
(8–28, 15) |
|
|
Location (C-A/T)
1
|
3/5 |
10/1 |
0.041 |
|
Crypt Branching
2
(+/total) |
0/8 |
8/11 |
0.003 |
|
Hypermucinous
3
(+/total) |
8/8 |
11/11 |
1.00 |
| Carcinoma in adenoma (+/total) | 0/8 | 1/11 | 1.00 |
1Anatomical location. Cecum (C). Ascending (A). Transversal (T).
2Crypt branching was defined by the appearance of splits or fissures in the base of the crypts.
3Hypermucinous appearance.
4P-values were calculated by Fisher’s exact test for categorical variables and unpaired t-test for continuous variables. P-values below 0.05 are in bold type.